المؤلفون: Tokimatsu I; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan. Electronic address: issei@med.showa-u.ac.jp., Matsumoto T; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Tsukada H; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; The Jikei University Kashiwa Hospital, Chiba, Japan., Fujikura Y; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; National Defense Medical College Hospital, Saitama, Japan., Miki M; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Japanese Red Cross Sendai Hospital, Miyagi, Japan., Morinaga Y; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Sato J; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Wakamura T; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Kiyota H; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Tateda K; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Yanagisawa H; MicroSKY Lab, Inc, Tokyo, Japan., Sasaki T; Asahikawa Medical University, Hokkaido, Japan., Ikeda H; Sanyudo Hospital, Yamagata, Japan., Horikawa H; Japanese Red Cross Sendai Hospital, Miyagi, Japan., Takahashi H; Saka General Hospital, Miyagi, Japan., Seki M; Tohoku Medical and Pharmaceutical University, Miyagi, Japan., Mori Y; Iwate Prefectural Central Hospital, Iwate, Japan., Takeda H; Saiseikai Yamagata Saisei Hospital, Yamagata, Japan., Kurai D; Kyorin University School of Medicine, Tokyo, Japan., Hasegawa N; Keio University School of Medicine, Tokyo, Japan., Uwamino Y; Keio University School of Medicine, Tokyo, Japan., Kudo M; Yokohama City University Medical Center, Kanagawa, Japan., Yamamoto M; Yokohama City University Medical Center, Kanagawa, Japan., Nagano Y; The Jikei University Kashiwa Hospital, Chiba, Japan., Nomura S; National Defense Medical College Hospital, Saitama, Japan., Tetsuka T; Niigata City General Hospital, Niigata, Japan., Hosokai M; Niigata City General Hospital, Niigata, Japan., Aoki N; Shinrakuen Hospital, Niigata, Japan., Yamamoto Y; Toyama University Hospital, Toyama, Japan., Iinuma Y; Kanazawa Medical University, Ishikawa, Japan., Mikamo H; Aichi Medical University Hospital, Aichi, Japan., Suematsu H; Aichi Medical University Hospital, Aichi, Japan., Maruyama T; National Hospital Organization Mie Hospital, Mie, Japan., Kawabata A; Toyota Memorial Hospital, Aichi, Japan., Sugaki Y; Toyota Memorial Hospital, Aichi, Japan., Nakamura A; Nagoya City University Hospital, Aichi, Japan., Fujikawa Y; Osaka City General Hospital, Osaka, Japan., Fukumori T; Center for Infectious Diseases, Nara Medical University, Nara, Japan., Ukimura A; Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan., Kakeya H; Osaka Metropolitan University Hospital, Osaka, Japan., Niki M; Osaka Metropolitan University Hospital, Osaka, Japan., Yoshida K; Kindai University Hospital, Osaka, Japan., Kobashi Y; Kawasaki Medical School Hospital, Okayama, Japan., Tokuyasu H; Matsue Red Cross Hospital, Shimane, Japan., Yatera K; University of Occupational and Environmental Health, Fukuoka, Japan., Ikegami H; University of Occupational and Environmental Health, Fukuoka, Japan., Fujita M; Faculty of Medicine, Fukuoka University, Fukuoka, Japan., Matsumoto T; Faculty of Medicine, Fukuoka University, Fukuoka, Japan., Yanagihara K; Nagasaki University School of Medicine, Nagasaki, Japan., Matsuda J; Nagasaki University School of Medicine, Nagasaki, Japan., Hiramatsu K; Oita University Faculty of Medicine, Oita, Japan., Shinzato T; Nakagami Hospital, Okinawa, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2023 Aug; Vol. 29 (8), pp. 731-743. Date of Electronic Publication: 2023 Apr 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Communicable Diseases*/drug therapy , Methicillin-Resistant Staphylococcus aureus* , Respiratory Tract Infections*/drug therapy , Respiratory Tract Infections*/epidemiology , Respiratory Tract Infections*/microbiology, Adult ; Humans ; Ampicillin ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Bacteria ; beta-Lactamases ; Drug Resistance, Bacterial ; Haemophilus influenzae ; Microbial Sensitivity Tests ; Japan

المؤلفون: Ishiwada N; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan. Electronic address: ishiwada@faculty.chiba-u.jp., Fujimaki K; The Surveillance Committee of JSC, JAID, and JSCM, Tokyo, Japan; Fujifilm Toyama Chemical Co., Ltd, Japan., Matsumoto T; The Surveillance Committee of JSC, JAID, and JSCM, Tokyo, Japan., Kiyota H; The Surveillance Committee of JSC, JAID, and JSCM, Tokyo, Japan., Tateda K; The Surveillance Committee of JSC, JAID, and JSCM, Tokyo, Japan., Sato J; The Surveillance Committee of JSC, JAID, and JSCM, Tokyo, Japan., Hanaki H; Infection Control Research Center, The Omura Satoshi Memorial Institution, Kitasato University, Tokyo, Japan., Takayanagi R; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Tohoku Rosai Hospital, Miyagi, Japan., Yamaguchi Y; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Infection and Allergy, Tochigi Medical Center, Tochigi, Japan., Hoshino T; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Division of Infections Diseases, Chiba Children's Hospital, Chiba, Japan., Kuroki H; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Sotobo Children's Clinic, Chiba, Japan., Iwata S; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Diseases, Keio University School of Medicine, Tokyo, Japan., Tajima T; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Hakujikai Memorial Hospital, Tokyo, Japan., Horikoshi Y; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Division of Infections Diseases, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan., Shiro H; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Yokohama Rosai Hospital, Kanagawa, Japan., Bamba M; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Kawasaki Municipal Hospital, Kanagawa, Japan., Kawamura N; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Osaka Rosai Hospital, Osaka, Japan., Ouchi K; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Kawasaki Medical School Hospital, Okayama, Japan., Matsubara K; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan., Okada T; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Shikoku Medical Center for Children and Adults, Kagawa, Japan., Furuno K; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan., Tsumura N; Pediatric Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID), The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Pediatrics, Kurume University Hospital, Fukuoka, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Feb; Vol. 27 (2), pp. 139-150. Date of Electronic Publication: 2020 Dec 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Communicable Diseases*/drug therapy , Respiratory Tract Infections*/drug therapy, Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Child ; Drug Resistance, Bacterial ; Escherichia coli ; Haemophilus influenzae ; Humans ; Japan/epidemiology ; Microbial Sensitivity Tests ; Tokyo

المؤلفون: Yanagihara K; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Nagasaki University School of Medicine, Nagasaki, Japan. Electronic address: k-yanagi@nagasaki-u.ac.jp., Matsumoto T; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Tokimatsu I; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Tsukada H; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Niigata City General Hospital, Niigata, Japan., Fujikura Y; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; National Defense Medical College Hospital, Saitama, Japan., Miki M; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Morinaga Y; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Nagasaki University School of Medicine, Nagasaki, Japan., Sato J; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Wakamura T; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Kiyota H; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Tateda K; The Surveillance Committee of the Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Hanaki H; Infection Control Research Center, Kitasato University, Tokyo, Japan., Fujiuchi S; National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan., Takahashi M; National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan., Kayaba H; Hirosaki University Hospital, Aomori, Japan., Mori Y; Iwate Prefectural Central Hospital, Iwate, Japan., Takeda H; Saisei kai Yamagata Saisei Hospital, Yamagata, Japan., Ikeda H; Sanyudo Hospital, Yamagata, Japan., Takahashi H; Saka General Hospital, Miyagi, Japan., Konno M; Saka General Hospital, Miyagi, Japan., Niitsuma K; Fukushima Medical University Aizu Medical Center, Fukushima, Japan., Niki Y; Showa University School of Medicine, Tokyo, Japan., Takuma T; Showa University School of Medicine, Tokyo, Japan., Kawana A; National Defense Medical College Hospital, Saitama, Japan., Kudo M; Yokohama City University Hospital, Kanagawa, Japan., Hirano T; Yokohama City University Hospital, Kanagawa, Japan., Miyazawa N; Saiseikai Yokohamashi Nanbu Hospital, Kanagawa, Japan., Aso S; Niigata City General Hospital, Niigata, Japan., Aoki N; Shinrakuen Hospital, Niigata, Japan., Honma Y; Shinrakuen Hospital, Niigata, Japan., Yamamoto Y; Toyama University Hospital, Toyama, Japan., Iinuma Y; Kanazawa Medical University, Ishikawa, Japan., Mikamo H; Aichi Medical University Hospital, Aichi, Japan., Yamagishi Y; Aichi Medical University Hospital, Aichi, Japan., Nakamura A; Nagoya City University Hospital, Aichi, Japan., Kondo S; Nagoya City University Hospital, Aichi, Japan., Kawabata A; Toyota Memorial Hospital, Aichi, Japan., Sugaki Y; Toyota Memorial Hospital, Aichi, Japan., Yamamoto T; Asahi Rosai Hospital, Aichi, Japan., Nishi I; Osaka University Hospital, Osaka, Japan., Hamaguchi S; Osaka University Hospital, Osaka, Japan., Kakeya H; Osaka City University Hospital, Osaka, Japan., Fujikawa Y; Osaka City General Hospital, Osaka, Japan., Mitsuno N; Osaka City General Hospital, Osaka, Japan., Ukimura A; Osaka Medical College Hospital, Osaka, Japan., Yoshida K; Kindai University Hospital, Osaka, Japan., Hayashi M; Sumitomo Hospital, Osaka, Japan., Mikasa K; Center for Infectious Diseases, Nara Medical University, Nara, Japan., Kasahara K; Center for Infectious Diseases, Nara Medical University, Nara, Japan., Tokuyasu H; Matsue Red Cross Hospital, Shimane, Japan., Hino S; Matsue Red Cross Hospital, Shimane, Japan., Shimizu E; Tottori University Hospital, Tottori, Japan., Chikumi H; Tottori University Hospital, Tottori, Japan., Fujita M; Faculty of Medicine, Fukuoka University, Fukuoka, Japan., Kadota J; Oita University Faculty of Medicine, Oita, Japan., Hiramatsu K; Oita University Faculty of Medicine, Oita, Japan., Suga M; Saiseikai Kumamoto Hospital, Kumamoto, Japan., Muranaka H; Saiseikai Kumamoto Hospital, Kumamoto, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2020 Sep; Vol. 26 (9), pp. 873-881. Date of Electronic Publication: 2020 Jun 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Communicable Diseases*/drug therapy , Methicillin-Resistant Staphylococcus aureus* , Respiratory Tract Infections*/drug therapy , Respiratory Tract Infections*/epidemiology, Adult ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Drug Resistance, Bacterial ; Haemophilus influenzae ; Humans ; Japan/epidemiology ; Microbial Sensitivity Tests

المؤلفون: Yanagihara K; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Nagasaki University School of Medicine, Nagasaki, Japan. Electronic address: k-yanagi@nagasaki-u.ac.jp., Matsumoto T; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Aoki N; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Sato J; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Wakamura T; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Kiyota H; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Tateda K; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan., Hanaki H; The Kitasato Institute, Tokyo, Japan., Ohsaki Y; Asahikawa Medical University, Hokkaido, Japan., Fujiuchi S; National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan., Takahashi M; National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan., Akiba Y; Asahikawa Kosei Hospital, Hokkaido, Japan., Masunaga S; Asahikawa Kosei Hospital, Hokkaido, Japan., Takeuchi K; Iwate Prefectural Central Hospital, Iwate, Japan., Takeda H; Saiseikai Yamagata Saisei Hospital, Yamagata, Japan., Miki M; Japanese Red Cross Sendai Hospital, Miyagi, Japan., Kumagai T; Japanese Red Cross Sendai Hospital, Miyagi, Japan., Takahashi H; Saka General Hospital, Miyagi, Japan., Utagawa M; Saka General Hospital, Miyagi, Japan., Nishiya H; Teikyo University Hospital, Tokyo, Japan., Kawakami S; Teikyo University Hospital, Tokyo, Japan., Ishigaki S; Teikyo University Hospital, Tokyo, Japan., Kobayasi N; National Center for Global Health and Medicine, Tokyo, Japan., Takasaki J; National Center for Global Health and Medicine, Tokyo, Japan., Mezaki K; National Center for Global Health and Medicine, Tokyo, Japan., Iwata S; Keio University Hospital, Tokyo, Japan., Katouno Y; Keio University Hospital, Tokyo, Japan., Inose R; Keio University Hospital, Tokyo, Japan., Niki Y; Showa University School of Medicine, Tokyo, Japan., Kawana A; National Defense Medical College Hospital, Saitama, Japan., Fujikura Y; National Defense Medical College Hospital, Saitama, Japan., Kudo M; Yokohama City University Hospital, Kanagawa, Japan., Hirano T; Yokohama City University Hospital, Kanagawa, Japan., Yamamoto M; Yokohama City University Hospital, Kanagawa, Japan., Miyazawa N; Saiseikai Yokohamashi Nanbu Hospital, Kanagawa, Japan., Tsukada H; Niigata City General Hospital, Niigata, Japan., Aso S; Niigata City General Hospital, Niigata, Japan., Yamamoto Y; Toyama University Hospital, Toyama, Japan., Iinuma Y; Kanazawa Medical University, Ishikawa, Japan., Mikamo H; Aichi Medical University Hospital, Aichi, Japan., Yamagishi Y; Aichi Medical University Hospital, Aichi, Japan., Nakamura A; Nagoya City University Hospital, Aichi, Japan., Ohashi M; Nagoya City University Hospital, Aichi, Japan., Kawabata A; Toyota Memorial Hospital, Aichi, Japan., Sugaki Y; Toyota Memorial Hospital, Aichi, Japan., Seki M; Osaka University Hospital, Osaka, Japan., Hamaguchi S; Osaka University Hospital, Osaka, Japan., Toyokawa M; Osaka University Hospital, Osaka, Japan., Kakeya H; Osaka City University Hospital, Osaka, Japan., Fujikawa Y; Osaka City General Hospital, Osaka, Japan., Mitsuno N; Osaka City General Hospital, Osaka, Japan., Ukimura A; Osaka Medical College Hospital, Osaka, Japan., Miyara T; Kansai Medical University Hospital, Osaka, Japan., Hayasi M; Sumitomo Hospital, Osaka, Japan., Mikasa K; Center for Infectious Diseases, Nara Medical University, Nara, Japan., Kasahara K; Center for Infectious Diseases, Nara Medical University, Nara, Japan., Koizumi A; Center for Infectious Diseases, Nara Medical University, Nara, Japan., Korohasi N; Nara Prefectural Gojo Hospital, Nara, Japan., Matumoto T; Nara Prefectural Gojo Hospital, Nara, Japan., Yosimura Y; Nara Prefectural Gojo Hospital, Nara, Japan., Katanami Y; Nara City Hospital, Nara, Japan., Takesue Y; Hyogo College of Medicine Hospital, Hyogo, Japan., Wada Y; Hyogo College of Medicine Hospital, Hyogo, Japan., Sugimoto K; Kobe Red Cross Hospital, Hyogo, Japan., Yamamoto T; Kobe City Nishi-Kobe Medical Center, Hyogo, Japan., Kuwabara M; Hiroshima Prefectural Hospital, Hiroshima, Japan., Doi M; Hiroshima Prefectural Hospital, Hiroshima, Japan., Simizu S; Hiroshima Prefectural Hospital, Hiroshima, Japan., Tokuyasu H; Matsue Red Cross Hospital, Shimane, Japan., Hino S; Matsue Red Cross Hospital, Shimane, Japan., Negayama K; Kagawa University Hospital, Kagawa, Japan., Mukae H; University of Occupational and Environmental Health Hospital, Fukuoka, Japan; Nagasaki University School of Medicine, Nagasaki, Japan., Kawanami T; University of Occupational and Environmental Health Hospital, Fukuoka, Japan., Yatera K; University of Occupational and Environmental Health Hospital, Fukuoka, Japan., Fujita M; Faculty of Medicine, Fukuoka University, Fukuoka, Japan., Kadota J; Oita University Faculty of Medicine, Oita, Japan., Hiramatsu K; Oita University Faculty of Medicine, Oita, Japan., Aoki Y; Saga University Hospital, Saga, Japan., Magarifuchi H; Saga University Hospital, Saga, Japan., Oho M; Saga University Hospital, Saga, Japan., Morinaga Y; Nagasaki University School of Medicine, Nagasaki, Japan., Suga M; Saiseikai Kumamoto Hospital, Kumamoto, Japan., Muranaka H; Saiseikai Kumamoto Hospital, Kumamoto, Japan., Fujita J; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Okinawa, Japan., Higa F; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Okinawa, Japan., Tateyama M; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Okinawa, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2019 Sep; Vol. 25 (9), pp. 657-668. Date of Electronic Publication: 2019 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Bacterial* , Epidemiological Monitoring*, Anti-Bacterial Agents/*therapeutic use , Respiratory Tract Infections/*prevention & control, Antimicrobial Stewardship ; Haemophilus influenzae/drug effects ; Humans ; Japan/epidemiology ; Klebsiella pneumoniae/drug effects ; Methicillin-Resistant Staphylococcus aureus/drug effects ; Microbial Sensitivity Tests ; Moraxella catarrhalis/drug effects ; Pseudomonas aeruginosa/drug effects ; Respiratory Tract Infections/microbiology ; Streptococcus pneumoniae/drug effects ; Streptococcus pyogenes/drug effects

المؤلفون: Watanabe A; The Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases and Japanese Society for Clinical Microbiology, c/o Japanese Society of Chemotherapy, Nichinai Kaikan B1, 3-28-8 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan., Yanagihara K, Matsumoto T, Kohno S, Aoki N, Oguri T, Sato J, Muratani T, Yagisawa M, Ogasawara K, Koashi N, Kozuki T, Komoto A, Takahashi Y, Tsuji T, Terada M, Nakanishi K, Hattori R, Hirako Y, Maruo A, Minamitani S, Morita K, Wakamura T, Sunakawa K, Hanaki H, Ohsaki Y, Honda Y, Sasaoka S, Takeda H, Ikeda H, Sugai A, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Kobayashi N, Takasaki J, Konosaki H, Aoki Y, Shoji M, Goto H, Saraya T, Kurai D, Okazaki M, Kobayashi Y, Katono Y, Kawana A, Saionji K, Miyazawa N, Sato Y, Watanuki Y, Kudo M, Ehara S, Tsukada H, Imai Y, Watabe N, Aso S, Honma Y, Mikamo H, Yamagishi Y, Takesue Y, Wada Y, Nakamura T, Mitsuno N, Mikasa K, Kasahara K, Uno K, Sano R, Miyashita N, Kurokawa Y, Takaya M, Kuwabara M, Watanabe Y, Doi M, Shimizu S, Negayama K, Kadota J, Hiramatsu K, Morinaga Y, Honda J, Fujita M, Iwata S, Iwamoto A, Ezaki T, Onodera S, Kusachi S, Tateda K, Tanaka M, Totsuka K, Niki Y, Matsumoto T

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2012 Oct; Vol. 18 (5), pp. 609-20. Date of Electronic Publication: 2012 Jul 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents/*pharmacology , Bacteria/*drug effects , Bacteria/*isolation & purification , Bacterial Infections/*microbiology , Respiratory Tract Infections/*microbiology, Bacteria/classification ; Bacterial Infections/epidemiology ; Chi-Square Distribution ; Drug Resistance, Bacterial ; Humans ; Japan/epidemiology ; Methicillin-Resistant Staphylococcus aureus/isolation & purification ; Microbial Sensitivity Tests/statistics & numerical data ; Public Health Surveillance ; Respiratory Tract Infections/epidemiology ; Societies, Scientific

المؤلفون: Tateda K

المصدر: Nihon Jibiinkoka Gakkai kaiho [Nihon Jibiinkoka Gakkai Kaiho] 2012 May; Vol. 115 (5), pp. 525-9.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oto-Rhino-Laryngological Society of Japan Country of Publication: Japan NLM ID: 7505728 Publication Model: Print Cited Medium: Print ISSN: 0030-6622 (Print) Linking ISSN: 00306622 NLM ISO Abbreviation: Nihon Jibiinkoka Gakkai Kaiho Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Bacterial*, Respiratory Tract Infections/*microbiology, Humans

المؤلفون: Matsumoto T; Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. tetsuya@tokyo-med.ac.jp, Matsumura K, Anwar KS, Mollah AH, Murakami H, Kobayashi I, Kawagoe K, Shiga S, Kishimoto T, Nahar N, Tateda K, Yamaguchi K

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2006 Jun; Vol. 12 (3), pp. 139-44.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print Cited Medium: Print ISSN: 1341-321X (Print) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Chlamydophila Infections/*epidemiology , Chlamydophila Infections/*microbiology , Chlamydophila pneumoniae/*isolation & purification , Respiratory Tract Infections/*epidemiology , Respiratory Tract Infections/*microbiology, Acute Disease ; Bangladesh/epidemiology ; Child, Preschool ; Enzyme-Linked Immunosorbent Assay/methods ; Female ; Fluorescent Antibody Technique ; Humans ; Infant ; Infant, Newborn ; Male ; Prevalence

المؤلفون: Miyazaki S; Department of Microbiology, Toho University School of Medicine, Tokyo, Japan. shuichi@med.Toho-u.ac.jp, Hosoyama T, Furuya N, Ishii Y, Matsumoto T, Ohno A, Tateda K, Yamaguchi K

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2001 Jan; Vol. 45 (1), pp. 203-7.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN: 0066-4804 (Print) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Carbapenems/*pharmacology , Respiratory Tract Infections/*microbiology, Animals ; Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/pharmacology ; Area Under Curve ; Carbapenems/pharmacokinetics ; Carbapenems/therapeutic use ; Haemophilus Infections/drug therapy ; Haemophilus Infections/microbiology ; Haemophilus influenzae/drug effects ; Male ; Mice ; Mice, Inbred CBA ; Mice, Inbred ICR ; Microbial Sensitivity Tests ; Prodrugs/pharmacokinetics ; Prodrugs/pharmacology ; Prodrugs/therapeutic use ; Respiratory Tract Infections/drug therapy ; Streptococcal Infections/drug therapy ; Streptococcal Infections/microbiology ; Streptococcus pneumoniae/drug effects

المؤلفون: Miyazaki S; Department of Microbiology, Toho University School of Medicine, Tokyo, Japan., Domon H, Tateda K, Ohno A, Ishii Y, Matsumoto T, Furuya N, Yamaguchi K

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1997 Nov; Vol. 41 (11), pp. 2582-5.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN: 0066-4804 (Print) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Fluoroquinolones*, Anti-Infective Agents/*therapeutic use , Piperazines/*therapeutic use , Quinolones/*therapeutic use , Respiratory Tract Infections/*drug therapy, Animals ; Anti-Infective Agents/pharmacokinetics ; Area Under Curve ; Female ; Humans ; Mice ; Mice, Inbred CBA ; Microbial Sensitivity Tests ; Piperazines/pharmacokinetics ; Quinolones/pharmacokinetics ; Staphylococcus/drug effects

المؤلفون: Matsumoto T; Department of Microbiology, Toho University School of Medicine, Tokyo, Japan., Kaku M, Tateda K, Furuya N, Hirakata Y, Yamaguchi K

المصدر: Microbiology and immunology [Microbiol Immunol] 1994; Vol. 38 (4), pp. 287-93.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 7703966 Publication Model: Print Cited Medium: Print ISSN: 0385-5600 (Print) Linking ISSN: 03855600 NLM ISO Abbreviation: Microbiol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Fluorescent Antibody Technique* , Immunoglobulins*, Bacteria/*isolation & purification , Respiratory Tract Infections/*diagnosis , Sputum/*microbiology, Adult ; Aged ; Aged, 80 and over ; Bacteria/growth & development ; Bacteria/immunology ; Bronchitis/diagnosis ; Bronchitis/microbiology ; Colony Count, Microbial ; Female ; Humans ; Lung Diseases, Obstructive/diagnosis ; Lung Diseases, Obstructive/microbiology ; Male ; Middle Aged ; Pneumonia, Bacterial/diagnosis ; Pneumonia, Bacterial/microbiology ; Tracheal Diseases/diagnosis ; Tracheal Diseases/microbiology